Factor VIII and Factor IX Mutation Analysis in 600 U.S. Hemophilia Patients: Correlation of Mutation Type with History of Inhibitor

More than 600 U.S. hemophilia patients have been genotyped as part of the pilot study for a prospective surveillance system for factor inhibitors conducted at 12 U.S. Hemophilia Treatment Centers. 80% of enrolled subjects had hemophilia A, 58% with severe disease, 24% moderate, and 18% mild. Age ran...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2008-11, Vol.112 (11), p.1017-1017
Main Authors: Miller, Connie H., Hooper, Craig, Abshire, Thomas C., Bockenstedt, Paula L., Brettler, Doreen B., Di Paola, Jorge, Massey, Gita, Neff, Anne T., Shapiro, Amy D., Tarantino, Michael, Wicklund, Brian M., Manco-Johnson, Marilyn J., Dunn, Amy L., Knoll, Christine, Creary, Melissa, Benson, Jane, Ellingsen, Dorothy, Driggers, Jennifer, Soucie, J. Michael
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:More than 600 U.S. hemophilia patients have been genotyped as part of the pilot study for a prospective surveillance system for factor inhibitors conducted at 12 U.S. Hemophilia Treatment Centers. 80% of enrolled subjects had hemophilia A, 58% with severe disease, 24% moderate, and 18% mild. Age ranged from
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V112.11.1017.1017